A Randomized, Double-Blind, Placebo-Controlled, Polysomnography Plus Outpatient Study to Determine the Safety and Efficacy of 4 mg Ramelteon in Adults With Chronic Insomnia.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Polysomnography Plus Outpatient Study to Determine the Safety and Efficacy of 4 mg Ramelteon in Adults With Chronic Insomnia.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Oct 2013

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Takeda Global Research and Development Center
  • Most Recent Events

    • 21 Mar 2012 This trial is recruting in England, Finland and France.
    • 21 Mar 2012 Planned patient number is 1200 according to European Clinical Trials Database.
    • 21 Mar 2012 Additional locations (Austria, England, Finland, France, Germany) added as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top